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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITOR3D Real-Time TEE During Pulmonary Vein
Isolation in Atrial FibrillationReal-time 3-dimensional transesophageal echocardi-
ography (RT3DTEE) has the potential of giving ﬂuo-
roless real-time images during electrophysiological
procedures (1). We sought to prospectively evaluate
the ability of RT3DTEE to visualize the pulmonary
vein (PV) ostia and to compare RT3DTEE and
the electroanatomic mapping system (EAMS) forFIGURE 1 RT3DTEE During Pulmonary Vein Isolation
(A) Image of the left superior pulmonary vein (LSPV) divided into 4 qua
and posteroinferior (PI). The ablation catheter is tracked in different qu
(C). (D) The pulmonary vein ostia and their quadrants from an anteropo
3-dimensional transesophageal echocardiography (RT3DTEE) and the ele
(95% conﬁdence intervals are shown in parentheses). (E) The relative po
left-rotated left atrium (LA) (superior view) determine a more open angl
catheter and the circular mapping electrode. The bubbles may interfere
appendage; LIPV ¼ left inferior pulmonary vein; LOM ¼ ligament of Ma
pulmonary vein.localizing the ablation catheter tip during pulmonary
vein isolation (PVI).
A total of 22 patients underwent PVI under general
anesthesia. Following an RT3DTEE-guided double
trans-septal puncture, a circumferential multipolar
catheter and an irrigated ablation catheter were
positioned in the left atrium (LA). For the creation of
the atrial geometry, the EAMS and ﬂuoroscopy were
used. Ablation was performed to encircle the antrum
of the veins.
RT3DTEE (Philips iE33 ultrasound system with an
X7-2t probe, Philips Medical Systems, Andover, Mas-
sachusetts) was performed as previously describeddrants: anterosuperior (AS), anteroinferior (AI), posterosuperior (PS),
adrants of the LSPV (B) and right superior pulmonary vein (RSPV)
sterior view are shown along with the agreement between real-time
ctroanatomic mapping system for the localization of the catheter tip
sition of the transesophageal echocardiography (TEE) probe and the
e of visualization for RSPV than for LSPV. (F) Overlap of the ablation
with the discrimination between the 2 catheters. LAA ¼ left atrial
rshall; LSPV ¼ left superior pulmonary vein; RIPV ¼ right inferior
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738(1). The left superior pulmonary vein (LSPV) was
visualized by using the zoom modality toward the
left atrial appendage followed by a counterclockwise
rotation. From that position, a gentle angulation of
the 3-dimensional image permitted visualization of
left inferior pulmonary vein (LIPV). When the septum
was in an “en face” perspective, a left-to-right 90
rotation disclosed the right PVs.
Visualization of the PVs by RT3DTEE was catego-
rized as “optimal” if the whole ostium was visualized,
“partial” if the ostial circumference could be partially
seen, or “none” if the PV ostium could not be iden-
tiﬁed or a good and stable visualization was not
possible.
To assess the position of the ablation catheter tip,
each ostium was divided into 4 quadrants (Fig. 1A).
Each position visualized on echocardiography was
assigned to a quadrant, and the same position was
assigned by 2 blinded electrophysiologists (M.A. and
F.R.) using EAMS (Figs. 1B and 1C).
The proportion of optimal, partial, and absent
visualization, as well as the true positive rate for
catheter location by RT3DTEE compared with EAMS,
was analyzed using logistic regression.
No periprocedural or post-procedural complication
was reported through 6 months of follow-up. In 4
patients, visualization of all PVs was possible, and 3
of 4 PVs were visualized in 11 patients. In 2 patients,
no PV could be visualized. The visualization was
optimal in 0.63 (95% conﬁdence interval [CI]: 0.52 to
0.73) of the LSPV cases and in 0.77 (95% CI: 0.67 to
0.85) of the right superior pulmonary vein (RSPV)
cases. One-half of the right inferior pulmonary vein
(RIPV) (95% CI: 0.39 to 0.60) and 0.47 of the LIPV
(95% CI: 0.35 to 0.59) cases could not be seen. No
chest deformity distorting the heart was present in
any case. The overall true positive rate for localiza-
tion of the ablation catheter tip per vein was low: 0.38
(95% CI: 0.31 to 0.46). The result was highly depen-
dent on the vein (logistic model p < 0.001); RSPV
showed a signiﬁcantly better agreement than RIPV
and LIPV (p < 0.008) (Fig. 1D).
Our results suggest that RT3DTEE has limited
value in identifying PV ostia and catheter location
during PVI. These results are contradictory to those
of Ottaviano et al. (2), who performed the same
echocardiographic technique using the cryoballoon
for PVI. Our negative results may be due to a number
of reasons. First, the natural left rotation of the heart
in the chest may give a sharper angle between the
transesophageal echocardiography probe and the
LSPV ostium compared to the RSPV (Fig. 1E).
LIPV and RIPV are less likely to be visualized due to
their relative posterior position, the sharper take-offfrom the atrium, and the smaller size of the ostia
compared with the superior veins. The supine position
of the patient could produce an anteroposterior pres-
sure of the atrium. In addition, having a rigid endo-
tracheal tubemay attenuate the freemovements of the
probe inside of the esophagus.
The metallic tip of the ablation catheter may
generate signiﬁcant acoustic artefacts (Fig. 1F) that,
when added to the previously mentioned handicaps,
could explain the poor accuracy in the localization of
the ablation catheter tip in comparison with EAMS.
Further studies are needed to evaluate whether the
use of RT3DTEE may have value in guiding PVI.Marta Acena, MD
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and Plaque RuptureIdentiﬁcation of vulnerable plaque pre-rupture is
extremely important for patient risk stratiﬁcation.
The mechanism of plaque rupture is still not entirely
clear, but it is thought to be a process involving
multiple factors. From a biomechanical viewpoint,
plaque rupture is usually seen as a structural failure
when the plaque cannot resist the hemodynamic
